Mar-2022
Vic Fedeli, Minister of Economic Development, Job Creation and Trade, was joined by Prabmeet Sarkaria, President of the Treasury Board, and Donna Skelly, MPP for Flamborough—Glanbrook, to make an announcement at McMaster Innovation Park
Invest Ontario is supporting OmniaBio Inc. in launching a new biomanufacturing facility that will catalyze Ontario life sciences jobs and innovation while advancing pioneering medicine with the potential to cure, not just treat, many forms of cancer, cardiovascular diseases, Parkinson’s and diabetes. OmniaBio, a Canadian cell and gene therapy contract development and manufacturing organization (CDMO), […]
Mar-2022
Ontario says it will provide a $40-million loan to the Centre for Commercialization of Regenerative Medicine for its planned $580-million Hamilton facility where life-science companies can develop and commercialize cell and gene therapies. The CCRM, a non-profit industry group, said Thursday that the facility will be run by a new subsidiary called OmniaBio Inc., which […]
Triumvira Immunologics, a clinical-stage company developing novel, targeted autologous and allogeneic T cell therapeutics that co-opt the natural biology of T cells to treat patients with solid tumors, today announced the completion of an extension of its Series A financing, bringing the total round to approximately $100 million. The Series A extension featured new investors, […]